Session » Epidemiology and Health Services Research IV: Outcomes and Costs in Rheumatic Disease
-
Abstract Number: 2461
Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis
-
Abstract Number: 2462
Projecting the Direct Cost Burden of Osteoarthritis in Canada Using a Population-Based Microsimulation Model From [2010-2031]
-
Abstract Number: 2463
Cost-Effectiveness of Tocilizumab Monotherapy Vs. Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis
-
Abstract Number: 2464
Cost-Sharing and Utilization of Biologic and Non-Biologic Dmards Among U.S. Medicare Beneficiaries with Rheumatoid Arthritis